Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPG Blocks vs Standard IV for Headache in ED
NCT04255420Phase 4Unknown
- Sponsor
- Kendall Healthcare
- Start
- Feb 2020
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Lidocaine Hydrochloride Injection, without epinephrine in Headache (2 arms), sponsored by Kendall Healthcare. Primary endpoint: Percentage of Patients with Substantial Pain Reduction at 15 minutes. Status: unknown.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
Headache
Beyond the preview
Go deeper on NCT04255420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04255420.